Eterna Therapeutics
ERNA
#10670
Rank
NZ$12.61 M
Marketcap
NZ$10.81
Share price
5.26%
Change (1 day)
146.76%
Change (1 year)

Eterna Therapeutics (ERNA) Fails to deliver data

Key failure to deliver metrics for Eterna Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eterna Therapeutics (ERNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eterna Therapeutics (ERNA) - since 2025

Volume in USD (price x number of shares), data since 2025

Eterna Therapeutics (ERNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026NZ$1.53 M-52.81%
2025NZ$3.25 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Sanofi
SNY
NZ$3.1 MNZ$45.62 M๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
NZ$15.19 MNZ$99.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
NZ$15.29 MNZ$29.57 M๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
NZ$3.34 MNZ$6.15 M๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/ANZ$0 M๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
NZ$5.49 MNZ$83.8 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
NZ$86.01 MNZ$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA